ロード中...
Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review
Erlotinib is among the oral EGFR-tyrosine kinase inhibitors used to treat non-small cell lung cancer. The common side effects of erlotinib include acne form rash and diarrhea. Eyelash trichomegaly and alterations of scalp hair are rarely observed symptoms. In the present study, we report changes in...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4998076/ https://ncbi.nlm.nih.gov/pubmed/27588051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3460 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|